A protein commonly found at high levels in lung cancer cells controls a major immunosuppressive pathway that allows lung tumors to evade immune attack, according to a study led by researchers at Weill Cornell Medicine. The discovery could hasten...
Read more
Our Director for Liquid Biopsy Research, Pashtoon Kasi, M.D., recently published an article, “Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices,” in the Journal of Clinical Oncology that is attracting a...
Read more
We are pleased to introduce you to our new colleague Majd Al Assaad, M.D., a Research Fellow in Precision Medicine in the Department of Pathology and Laboratory Medicine, and a Member of the Englander Institute for Precision Medicine. Dr. Assaad...
Read more
November 2021 EIPM Director’s Memo Dear Members of the Englander Institute, It’s always a pleasure to share the important work and contributions of our colleagues, especially those who are just beginning their careers. Over the next...
Read more
Spring 2021 Newsletter Dear friend of the Englander Institute for Precision Medicine, Welcome to our first quarterly newsletter of 2021! Thank you for signing-up on our website to receive this newsletter, we hope you enjoy learning...
Read more
Patient-Centered Approach in Treating Thymoma Life at 40 years old was good for Amara MacPhee. She’d lost about 40 pounds, was eating well, enjoyed spending time outside, and, even with a busy professional life, was able to carve out time for...
Read more December 31, 2020 Dear Friends of the EIPM, Welcome to our final quarterly newsletter of the 2020! You signed-up on our website to receive this newsletter, and we hope you enjoy learning more about our researchers and the breakthroughs they are...
Read more
Podcast: Addressing Breast Cancer Care Disparities Within Diverse Populations In this episode of Back to Health, Englander Institute for Precision Medicine Member Lisa Newman, M.D. (left) and Vivian Bea, M.D. discuss the importance of early...
Read more
December 01, 2020 Dear Members of the Englander Institute, The past year will be remembered for the heroic response by the medical community to treat Covid-19 patients, and by the investigators who developed effective treatments and vaccines with...
Read more
The EIPM External Newsletter below is sent quarterly to people who sign-up on our website. Dear Friends of the EIPM: During these extraordinary times we have continued to create breakthroughs in basic research that will benefit patients with...
Read more
NYGC Launches Collaborative Cancer Genomics Research Projects Focused on Underserved Populations NEW YORK, NY (September 8, 2020) – Leading cancer scientists working with the New York Genome Center (NYGC) announced today that grants are...
Read more
Dr. Bishoy Faltas Works to Develop More Effective Therapies for Bladder Cancer Each year, 80,000 people in the United States are newly diagnosed with bladder cancer, and more than 17,000 lose their lives due to the disease. It ranks as the fourth...
Read more